SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 66963.00 millions for the September 2024 quarter. The mentioned figure indicates a growth of about 38.39% as compared to Rs. 48387.00 millions during the year-ago period.Handsome Net Profit growth of 57.81% reported above the corresponding previous quarter figure of Rs. 18821.00 millions to Rs. 11926.00 millions.Operating Profit saw a handsome growth to 29292.00 millions from 18522.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 66963.00 48387.00 38.39 125375.00 102760.00 22.01 194838.00 169625.00 14.86
Other Income 2076.00 2231.00 -6.95 4254.00 4567.00 -6.85 8623.00 5913.00 45.83
PBIDT 29292.00 18522.00 58.15 51000.00 43135.00 18.23 67887.00 48061.00 41.25
Interest 284.00 58.00 389.66 355.00 103.00 244.66 218.00 169.00 28.99
PBDT 29008.00 18464.00 57.11 50645.00 43032.00 17.69 67669.00 47892.00 41.29
Depreciation 2600.00 2458.00 5.78 5098.00 4830.00 5.55 9756.00 9232.00 5.68
PBT 26408.00 16006.00 64.99 45547.00 38202.00 19.23 57913.00 38660.00 49.80
TAX 7587.00 4080.00 85.96 12554.00 9882.00 27.04 14493.00 12532.00 15.65
Deferred Tax 554.00 120.00 361.67 855.00 535.00 59.81 875.00 3891.00 -77.51
PAT 18821.00 11926.00 57.81 32993.00 28320.00 16.50 43420.00 26128.00 66.18
Equity 834.00 834.00 0.00 834.00 834.00 0.00 834.00 833.00 0.12
PBIDTM(%) 43.74 38.28 14.28 40.68 41.98 -3.09 34.84 28.33 22.97

Dr. Reddys Lab Share Price

1271.55 3.75 (0.30%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: